Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,330,759
-$1,387,526 QoQ
Shares Held
25,158
-29.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,171
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $34,699,600 across 10 Drug Manufacturers - General names. ABBV ranks #2 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,327 | $6,389,364 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
25,158 | $6,330,759 | |
| 3 | JNJ |
Johnson & Johnson
|
18,196 | $4,621,238 | |
| 4 | AMGN |
Amgen Inc
|
10,362 | $3,752,287 | |
| 5 | PFE |
Pfizer Inc
|
154,984 | $3,732,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
22,416 | $2,832,037 | |
| 7 | NVS |
Novartis AG
|
16,110 | $2,524,759 | |
| 8 | GSK |
GSK plc
|
41,506 | $2,175,744 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,330,759 | 25,158 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,718,285 | 35,488 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $8,250,316 | 36,108 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,354,362 | 23,125 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $4,602,633 | 24,796 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $5,246,380 | 25,040 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,929,657 | 22,114 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $4,454,753 | 22,558 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,916,830 | 22,836 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $3,935,909 | 21,614 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,480,781 | 22,461 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,489,345 | 23,409 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $3,024,149 | 22,446 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,314,577 | 20,798 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $3,236,725 | 20,028 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,498,453 | 18,616 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $2,978,808 | 19,449 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,605,650 | 22,242 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,730,205 | 20,164 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,536,994 | 23,519 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $2,271,272 | 20,164 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,816,689 | 16,787 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,331,767 | 12,429 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,047,401 | 11,958 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,453,849 | 14,808 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $372,492 | 4,889 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||